Company Profile - JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 09 August 2024 20:12 Company Profile JSP

Facebook page “TCP Group” impersonates “T.C. Pharmaceutical Industries Co., Ltd.” : Unlicensed securities and derivatives business (Disclosure Date : 05/08/2024)

Type of securities : Common share | Effective Date : 19/10/2021 | Close Selling Date : 26/10/2021

company and its subsidiaries has revised its strategies to cope with the situation by focusing its marketing towards industries least impacted by the coronavirus, such as the food and pharmaceutical

result, gross margin improved from 28% in 9M16 to 30% yoy and from 30% in 3Q16 to 33% yoy. This improvement was not only contributed by the increase of bill amount and social security payment rate but also

the same period of the year earlier and has gross profit margin of 31.89%. because the company has improved the structure within the organization. The company has administrative expenses of THB 3.56

Attn : The Directors and The MAI Manager Ref: Dimet AC 1802/001 February 13, 2018 Attention: The Directors and The MAI Manager The Stock Exchange of Thailand Subject: Report on improved Q.2’s

margin of (11.49%). because the company has improved the structure within the organization The company has administrative expenses of THB 7.62 million, increase of THB 1.17 million or 18.03% compared to

decreased year-on-year, attributable to improved efficiency as well as on-going cost reduction and cost control. Hence, gross profit margin improved from 7.0% of sales in Q1 2016 to 7.7% of sales in Q1 2017

the form of outsourcing or partnership. In this regard, the partnership-based business operation guidelines must be improved from the SEC circular in this matter. SEC has therefore proposed issuance of